Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Host-Guest Chemistry in Supramolecular TheranosticsTheranostics, 2019-01, Vol.9 (11), p.3041-3074 [Peer Reviewed Journal]Ivyspring International Publisher 2019 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.31653 ;PMID: 31244941Full text available |
|
2 |
Material Type: Article
|
Recent Advances of Light-Mediated TheranosticsTheranostics, 2016-01, Vol.6 (13), p.2439-2457 [Peer Reviewed Journal]Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. 2016 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.16088 ;PMID: 27877246Full text available |
|
3 |
Material Type: Article
|
67 Cu Production Capabilities: A Mini ReviewMolecules (Basel, Switzerland), 2022-03, Vol.27 (5) [Peer Reviewed Journal]EISSN: 1420-3049 ;DOI: 10.3390/molecules27051501 ;PMID: 35268600Full text available |
|
4 |
Material Type: Article
|
Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranosticsTheranostics, 2018-01, Vol.8 (12), p.3284-3307 [Peer Reviewed Journal]Ivyspring International Publisher 2018 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.25220 ;PMID: 29930730Full text available |
|
5 |
Material Type: Article
|
Recent advances in nanotheranostics for triple negative breast cancer treatmentJournal of experimental & clinical cancer research, 2019-10, Vol.38 (1), p.430-22, Article 430 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1443-1 ;PMID: 31661003Full text available |
|
6 |
Material Type: Article
|
Recent Developments of Liposomes as Nanocarriers for Theranostic ApplicationsTheranostics, 2016-01, Vol.6 (9), p.1336-1352 [Peer Reviewed Journal]Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. 2016 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.15464 ;PMID: 27375783Full text available |
|
7 |
Material Type: Article
|
RADIOLIGAND THERAPY IN LYMPHOMA: PAST, PRESENT AND FUTUREHematology, Transfusion and Cell Therapy, 2024-04, Vol.46, p.S40 [Peer Reviewed Journal]ISSN: 2531-1379Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Editorial: Radiomics-based theranostics in cancer precision medicineFrontiers in oncology, 2023-09, Vol.13, p.1250079-1250079 [Peer Reviewed Journal]Copyright © 2023 Ji, Ju and Cai 2023 Ji, Ju and Cai ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1250079Full text available |
|
9 |
Material Type: Article
|
Ferritins as natural and artificial nanozymes for theranosticsTheranostics, 2020, Vol.10 (2), p.687-706 [Peer Reviewed Journal]The author(s). ;2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The author(s) 2020 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.39827 ;PMID: 31903145Full text available |
|
10 |
Material Type: Article
|
Theranostic Risk Stratification for Thyroid Cancer in the Genomic ParadigmCancers, 2024-04, Vol.16 (8), p.1585 [Peer Reviewed Journal]2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers16081585 ;PMID: 38672667Full text available |
|
11 |
Material Type: Article
|
Magnetic Drug Delivery: Where the Field Is GoingFrontiers in chemistry, 2018-12, Vol.6, p.619-619 [Peer Reviewed Journal]Copyright © 2018 Price, Mahmoud, Al-Ghamdi and Bronstein. 2018 Price, Mahmoud, Al-Ghamdi and Bronstein ;ISSN: 2296-2646 ;EISSN: 2296-2646 ;DOI: 10.3389/fchem.2018.00619 ;PMID: 30619827Full text available |
|
12 |
Material Type: Article
|
Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairsTheranostics, 2022, Vol.12 (1), p.232-259 [Peer Reviewed Journal]The author(s). ;2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The author(s) 2022 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/THNO.62851 ;PMID: 34987643Full text available |
|
13 |
Material Type: Article
|
Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu ReactionPharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (2), p.314 [Peer Reviewed Journal]2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 1424-8247 ;EISSN: 1424-8247 ;DOI: 10.3390/ph16020314Full text available |
|
14 |
Material Type: Article
|
Smart Nanotheranostics Responsive to Pathological StimuliFrontiers in bioengineering and biotechnology, 2020-05, Vol.8, p.503-503 [Peer Reviewed Journal]Copyright © 2020 Parodi, Rudzinska, Leporatti, Anissimov and Zamyatnin. 2020 Parodi, Rudzinska, Leporatti, Anissimov and Zamyatnin ;ISSN: 2296-4185 ;EISSN: 2296-4185 ;DOI: 10.3389/fbioe.2020.00503 ;PMID: 32523946Full text available |
|
15 |
Material Type: Article
|
Stimuli-activatable nanomedicine meets cancer theranosticsTheranostics, 2023-01, Vol.13 (15), p.5386-5417 [Peer Reviewed Journal]The author(s) 2023 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.87854Full text available |
|
16 |
Material Type: Article
|
PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand TherapyCancers, 2020-05, Vol.12 (6), p.1367 [Peer Reviewed Journal]2020 by the authors. 2020 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers12061367 ;PMID: 32466595Full text available |
|
17 |
Material Type: Article
|
Editorial: Recent progress in drug delivery technologies for advanced pharmaceuticsFrontiers in chemistry, 2024, Vol.12, p.1413056-1413056 [Peer Reviewed Journal]Copyright © 2024 Guo, Peng, Hu and Qiao. 2024 Guo, Peng, Hu and Qiao ;ISSN: 2296-2646 ;EISSN: 2296-2646 ;DOI: 10.3389/fchem.2024.1413056 ;PMID: 38721010Full text available |
|
18 |
Material Type: Article
|
Dependence of Nanoparticle Toxicity on Their Physical and Chemical PropertiesNanoscale research letters, 2018-02, Vol.13 (1), p.44-21, Article 44 [Peer Reviewed Journal]The Author(s). 2018 ;Attribution ;ISSN: 1931-7573 ;EISSN: 1556-276X ;DOI: 10.1186/s11671-018-2457-x ;PMID: 29417375Full text available |
|
19 |
Material Type: Article
|
Recent Trends of the Bio-Inspired Nanoparticles in Cancer TheranosticsFrontiers in pharmacology, 2019-10, Vol.10, p.1264-1264 [Peer Reviewed Journal]COPYRIGHT 2019 Frontiers Research Foundation ;Copyright © 2019 Madamsetty, Mukherjee and Mukherjee 2019 Madamsetty, Mukherjee and Mukherjee ;ISSN: 1663-9812 ;EISSN: 1663-9812 ;DOI: 10.3389/fphar.2019.01264 ;PMID: 31708785Full text available |
|
20 |
Material Type: Article
|
3D Cell Printed Tissue Analogues: A New Platform for TheranosticsTheranostics, 2017-01, Vol.7 (12), p.3118-3137 [Peer Reviewed Journal]Ivyspring International Publisher 2017 ;ISSN: 1838-7640 ;EISSN: 1838-7640 ;DOI: 10.7150/thno.19396 ;PMID: 28839468Full text available |